Join the club for FREE to access the whole archive and other member benefits.

Skin cancer survival rate up jumps 10-fold in just 10 years


Key points from article :

Melanoma is the 5 most common cancer in the UK and kills nearly 2,300 people each year.

Ten years ago only 1-in-20 patients would live for 5 years with advanced melanoma.

People tended to live between six and nine months after diagnosis.

Trial with 945 patients investigated 2 immunotherapy drugs - nivolumab and ipilimumab.

52% of patients were still alive when given both drugs

Three-quarters of the survived patients no longer need any form of cancer treatment.

Some patients taking the drugs are in total remission with no sign of any abnormality on scans.

Side effects can be fatigue, skin rashes and diarrhoea.

Findings have been published in the New England Journal of Medicine.

UK doctors announce that more than half of the patients can now survive advanced melanoma

Mentioned in this article:

Click on resource name for more details.

James Larkin

Consultant Medical Oncologist at Royal Marsden NHS Foundation Trust.

Royal Marsden NHS Foundation Trust

Hospital dedicated to cancer diagnosis, treatment, research and education.

The New England Journal of Medicine

Scientific Journal devoted to medical research.